![Course Staff Image #1](https://d24jp206mxeyfm.cloudfront.net/static/images/placeholder-faculty.4640df65662e.png)
Dr Astrid Irwanto
After obtaining her PhD in genetics in Genome Institute of Singapore, Dr Irwanto went on to start Nalagenetics along with three other scientists in GIS. She is currently the Chief Operating Officer at Nalagenetics.
"Risk Prediction for Breast Cancer" is a short introduction to the clinical genetics and non-genetics approach in predicting the occurrence of breast cancer in women. You will learn the current status of breast cancer and its available treatments, the multiple factors affecting breast cancer risk and the state-of-art scientific advancement in predicting breast cancer risk.
-
After obtaining her PhD in genetics in Genome Institute of Singapore, Dr Irwanto went on to start Nalagenetics along with three other scientists in GIS. She is currently the Chief Operating Officer at Nalagenetics.
Product Intern, Nalagenetics under the supervision of Astrid Irwanto.
The Open edX platform works best with current versions of Chrome, Edge, Firefox, Internet Explorer, or Safari.
See our list of supported browsers for the most up-to-date information.